SHAWN BROWN: Open Payments
NPI 1629065073 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,411 in 30 payments from 9 companies in 2025. Trend: 2023 $836 · 2024 $828 · 2025 $1,411
Food & beverage: $1,411
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $338 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $167 |
| Otsuka America Pharmaceutical, Inc. | 5 | $154 |
| KYOWA KIRIN, INC. | 1 | $140 |
| Dexcom, Inc. | 5 | $137 |
| Amgen Inc. | 3 | $136 |
| ABIOMED | 1 | $125 |
| GENZYME CORPORATION | 1 | $122 |
| ABBVIE INC. | 1 | $92 |
Products named: CAPLYTA, REXULTI, CRYSVITA, FABRAZYME, KRYSTEXXA, BREZTRI, AIRSUPRA, DEXCOM G7 GSS (161).
Industry payments across MO — which companies pay providers there.
